Market Cap 29.20B
Revenue (ttm) 4.34B
Net Income (ttm) 850.00M
EPS (ttm) N/A
PE Ratio 37.67
Forward PE 36.33
Profit Margin 19.57%
Debt to Equity Ratio 0.56
Volume 1,693,900
Avg Vol 1,875,398
Day's Range N/A - N/A
Shares Out 151.30M
Stochastic %K 79%
Beta 1.47
Analysts Sell
Price Target $171.95

Company Profile

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other g...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 858 202 4500
Fax: 858 202 4766
Address:
5200 Illumina Way, San Diego, United States
hitmongreen
hitmongreen Jul. 28 at 12:28 AM
$ILMN 👀
0 · Reply
IDrawLiness
IDrawLiness Jul. 26 at 11:27 PM
0 · Reply
tarzzanman
tarzzanman Jul. 23 at 7:46 PM
$ILMN Badboy gonna break that 200$
0 · Reply
WAJeff
WAJeff Jul. 23 at 3:48 PM
$ILMN 199.14 52 week high
0 · Reply
JFDI
JFDI Jul. 21 at 2:07 PM
$ILMN big bar
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 17 at 11:03 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 17 at 6:07 PM
$SLS Major Pharmaceutical/Oncology Leaders:AstraZeneca (NASDAQ: AZN): ~$75.00 – $80.00 rangeNovartis (NYSE: NVS): ~$110.00 – $115.00 rangeMerck & Co. (NYSE: $MRK): ~$120.00 – $125.00 rangeEli Lilly (NYSE: LLY): ~$900.00 – $950.00 rangeSpecialized Cancer Biotech & Diagnostics Leaders:Guardant Health (NASDAQ: $GH): ~$150.00 – $155.00 rangeIllumina (NASDAQ: $ILMN): ~$185.00 – $190.00 range . All interested in the winner $SLS.
0 · Reply
HiringLawyers
HiringLawyers Jul. 16 at 5:53 PM
$ILMN well, this is nice!
0 · Reply
DrewskiC99
DrewskiC99 Jul. 15 at 3:49 PM
$ILMN this aged well. Exited
1 · Reply
VTLefevre
VTLefevre Jul. 8 at 3:35 PM
$XLE $SFD trying to take fewer trades. Focus on these 2, would like to add $ILMN in the lower 180s
0 · Reply
Latest News on ILMN
Illumina price target raised to $210 from $175 at Leerink

2026-07-17T12:50:39.000Z - 12 days ago

Illumina price target raised to $210 from $175 at Leerink


Illumina price target raised to $192 from $140 at TD Cowen

2026-07-15T12:45:54.000Z - 14 days ago

Illumina price target raised to $192 from $140 at TD Cowen


Illumina price target raised to $190 from $140 at Canaccord

2026-07-14T10:56:23.000Z - 15 days ago

Illumina price target raised to $190 from $140 at Canaccord


Illumina appoints Sullivan as CCO, Coletti as CLO

2026-07-09T13:20:39.000Z - 20 days ago

Illumina appoints Sullivan as CCO, Coletti as CLO

CAI


Illumina price target raised to $200 from $180 at Guggenheim

2026-06-29T11:06:22.000Z - 4 weeks ago

Illumina price target raised to $200 from $180 at Guggenheim


Illumina resumed with a Market Perform at Bernstein

2026-06-26T10:30:23.000Z - 4 weeks ago

Illumina resumed with a Market Perform at Bernstein


Illumina price target raised to $145 from $122 at Barclays

2026-06-24T08:55:36.000Z - 5 weeks ago

Illumina price target raised to $145 from $122 at Barclays


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 6 weeks ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


Illumina upgraded to Overweight from Neutral at JPMorgan

2026-06-10T09:35:08.000Z - 7 weeks ago

Illumina upgraded to Overweight from Neutral at JPMorgan


Illumina (ILMN): Bullish Structure Builds After Breakout

Jun 9, 2026, 5:10 PM EDT - 7 weeks ago

Illumina (ILMN): Bullish Structure Builds After Breakout


Illumina price target raised to $180 from $170 at Guggenheim

2026-06-01T11:50:48.000Z - 2 months ago

Illumina price target raised to $180 from $170 at Guggenheim


Illumina announces new complete solution for MRD research

2026-05-28T14:32:27.000Z - 2 months ago

Illumina announces new complete solution for MRD research


Illumina appoints David King to board of directors

2026-05-21T20:22:02.000Z - 2 months ago

Illumina appoints David King to board of directors

LH


David P. King elected to Illumina's Board of Directors

May 21, 2026, 4:15 PM EDT - 2 months ago

David P. King elected to Illumina's Board of Directors


Illumina Transcript: AGM 2026

May 21, 2026, 1:00 PM EDT - 2 months ago

Illumina Transcript: AGM 2026


Illumina Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Illumina Earnings Call Transcript: Q1 2026


Illumina Earnings release: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Illumina Earnings release: Q1 2026


Illumina Slides: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Illumina Slides: Q1 2026


Illumina Quarterly report: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Illumina Quarterly report: Q1 2026


Illumina Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 3 months ago

Illumina Proxy statement: Proxy filing


Illumina Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 3 months ago

Illumina Proxy statement: Proxy filing


Illumina Announces Changes to Board of Directors

Apr 2, 2026, 9:07 AM EDT - 4 months ago

Illumina Announces Changes to Board of Directors


Illumina To Webcast Upcoming Investor Conference

Feb 17, 2026, 3:10 PM EST - 5 months ago

Illumina To Webcast Upcoming Investor Conference


Illumina Earnings Call Transcript: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Illumina Earnings Call Transcript: Q4 2025


Illumina Annual report: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Illumina Annual report: Q4 2025


Illumina Earnings release: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Illumina Earnings release: Q4 2025


Illumina Slides: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Illumina Slides: Q4 2025


Illumina completes acquisition of SomaLogic

Jan 30, 2026, 9:05 AM EST - 6 months ago

Illumina completes acquisition of SomaLogic


Illumina Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 10:30 AM EST - 7 months ago

Illumina Transcript: 44th Annual J.P. Morgan Healthcare Conference


Illumina Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 10:30 AM EST - 7 months ago

Illumina Slides: 44th Annual J.P. Morgan Healthcare Conference


Illumina unveils dataset to speed up AI-powered drug discovery

Jan 13, 2026, 9:18 AM EST - 7 months ago

Illumina unveils dataset to speed up AI-powered drug discovery


Illumina Appoints Dr. Eric Green as Chief Medical Officer

Jan 8, 2026, 4:30 PM EST - 7 months ago

Illumina Appoints Dr. Eric Green as Chief Medical Officer


Illumina Transcript: Wolfe Research Healthcare Conference 2025

Nov 19, 2025, 9:20 AM EST - 9 months ago

Illumina Transcript: Wolfe Research Healthcare Conference 2025


Illumina Earnings Call Transcript: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 9 months ago

Illumina Earnings Call Transcript: Q3 2025


Illumina Quarterly report: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 9 months ago

Illumina Quarterly report: Q3 2025


Illumina Earnings release: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 9 months ago

Illumina Earnings release: Q3 2025


Illumina Slides: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 9 months ago

Illumina Slides: Q3 2025


hitmongreen
hitmongreen Jul. 28 at 12:28 AM
$ILMN 👀
0 · Reply
IDrawLiness
IDrawLiness Jul. 26 at 11:27 PM
0 · Reply
tarzzanman
tarzzanman Jul. 23 at 7:46 PM
$ILMN Badboy gonna break that 200$
0 · Reply
WAJeff
WAJeff Jul. 23 at 3:48 PM
$ILMN 199.14 52 week high
0 · Reply
JFDI
JFDI Jul. 21 at 2:07 PM
$ILMN big bar
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 17 at 11:03 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 17 at 6:07 PM
$SLS Major Pharmaceutical/Oncology Leaders:AstraZeneca (NASDAQ: AZN): ~$75.00 – $80.00 rangeNovartis (NYSE: NVS): ~$110.00 – $115.00 rangeMerck & Co. (NYSE: $MRK): ~$120.00 – $125.00 rangeEli Lilly (NYSE: LLY): ~$900.00 – $950.00 rangeSpecialized Cancer Biotech & Diagnostics Leaders:Guardant Health (NASDAQ: $GH): ~$150.00 – $155.00 rangeIllumina (NASDAQ: $ILMN): ~$185.00 – $190.00 range . All interested in the winner $SLS.
0 · Reply
HiringLawyers
HiringLawyers Jul. 16 at 5:53 PM
$ILMN well, this is nice!
0 · Reply
DrewskiC99
DrewskiC99 Jul. 15 at 3:49 PM
$ILMN this aged well. Exited
1 · Reply
VTLefevre
VTLefevre Jul. 8 at 3:35 PM
$XLE $SFD trying to take fewer trades. Focus on these 2, would like to add $ILMN in the lower 180s
0 · Reply
WAJeff
WAJeff Jul. 6 at 4:38 PM
$ILMN $193.72 52 week high
0 · Reply
M_Chromatic
M_Chromatic Jul. 2 at 4:10 PM
$ILMN Weekly chart with volume profile. Right up against the volume shelf. Let's see if Illumina will work through any potential sell orders that might be here. If so, I don't see a lot of overhead supply above 204.
0 · Reply
Johnny_Lever
Johnny_Lever Jul. 2 at 12:53 AM
$ILMN Up 16% since breaking through that inverse H&S neckline. The hourly chart showing the back-test and support at neckline. Now moving higher.
0 · Reply
Clargy
Clargy Jul. 1 at 8:26 PM
$ILMN So many biotech/genomic names acting extremely constructive. Healthiest looking industry by far.
0 · Reply
WAJeff
WAJeff Jul. 1 at 7:56 PM
$ILMN $184.75 52 week high
0 · Reply
macapower
macapower Jul. 1 at 6:58 PM
$PACB $ILMN Strategic Notes #1 Could SPRQ-Nx change Illumina’s strategic incentives regarding PACB Most ask: “Would partnering strengthen PacBio too much?” I think the more important question is: Would an acquired PACB strengthen one of Illumina’s competitors more than a strengthened independent PACB operating within a mutually beneficial partnership? Illumina previously tried to acquire PacBio because it viewed HiFi as strategically important. If Spark materially improves the economics and scalability of HiFi, waiting could increases PACB’s bargaining power while also increasing the chance that another major industry player becomes interested. Viewed this way, a partnership could represent strategic risk management rather than simply accelerating PacBio’s growth. Strategic hypothesis only—not a prediction. Disclosure: My analysis. ChatGPT assisted with editing. Not investment advice. Question: Which assumption is weakest?
1 · Reply
tarzzanman
tarzzanman Jun. 30 at 8:25 PM
$ILMN Let me see that 200$+
1 · Reply
Sunnytrading90
Sunnytrading90 Jun. 30 at 1:08 PM
$ILMN monster
0 · Reply
JFDI
JFDI Jun. 30 at 12:57 PM
$ILMN breaking out
0 · Reply
UpgradeDowngrade
UpgradeDowngrade Jun. 30 at 2:27 AM
$ILMN Bernstein has altered their rating of "Mkt Perform" and target of "$185" see consensus outlook
0 · Reply
G101SPM
G101SPM Jun. 26 at 2:22 PM
#INSIDERS $BZUN Chief Strategy Officer bought 29,000 American Depositary Shares worth approximately $83K (transaction date 6)./24 PGY Chief Executive Officer bought 16,230 Class A Ordinary Shares at $15.409 - $15.44WORTH approximately $250K (transaction date 6/24). $PSEC Chief Executive Officer / 10% owner bought 1,067,648 shares worth approximately $2.4 mln (transaction date 6/23). $ILMN Chief Legal Officer sold 615 shares at $180.00 worth approximately $111K (transaction date 6/25).
0 · Reply